ACE inhibitor quinapril in the treatment of chronic cardiac failure

ACE inhibitor quinapril in the treatment of chronic cardiac failure

Aim. To assess effectiveness of A CE inhibitor quinapril in patients with moderate cardiac failure of ischemic etiology. Material and methods. 20 patients received quinapril in a daily dose 20 mgfor 6 months. Clinical condition, exercise tolerance, functional and geometric parameters of the left ven...

Full description

Bibliographic Details
Main Author:	A N Gadzhiev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2003-01-01
Series:	Терапевтический архив
Subjects:	chronic heart failure inhibitors of angiotensin convening enzyme left ventricle remodeling heart rhythm variability late potentials
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29292

Similar Items

Heart rate variability and structural and functional disorders of myocardium in patients with chronic prostatitis
by: D. N. Zaitsev, et al.
Published: (2013-04-01)

NT-proBNP LEVEL CHANGES AFTER COMBINATION THERAPY WITH BISOPROLOL AND ACE-INHIBITOR IN PATIENT WITH HEART FAILURE
by: Reine Risa Risthanti, et al.
Published: (2017-08-01)

Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study
by: Yue-Jin Yang, et al.
Published: (2016-01-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
by: Urszula Tyrankiewicz, et al.
Published: (2021-06-01)

Renal and Myocardial Histopathology and Morphometry in Rats with Adenine - Induced Chronic Renal Failure: Influence of Gum Acacia
by: Badreldin H. Ali, et al.
Published: (2014-08-01)

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience
by: А. О. Shevchenko, et al.
Published: (2019-01-01)

POST-MI REMODELING OF THE LEFT VENTRICLE REMODELING: A CARDIAC SURGEON’S STANDPOINT
by: Y. V. Belov, et al.
Published: (2002-10-01)

Heart rate variability, structural and functional characteristics of the left ventricle in essential arterial hypertension
by: Khromtsova О.М.
Published: (2010-09-01)

IS THERE AN ALTERNATIVE TO EJECTION FRACTION IN INSTRUMENTAL EVALUATION OF CHRONIC HEART FAILURE SEVERITY IN POST-MYOCARDIAL INFARCTION PATIENTS?
by: T. A. Kazakovtseva, et al.
Published: (2016-01-01)

How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
by: Dickstein Kenneth, et al.
Published: (2001-06-01)

Left Ventricle Remodeling for Patients with Heart Failure and its Influence on Cardiac Performance
by: Durra A. Ahmed, et al.
Published: (2013-07-01)

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
by: I. V. Zhirov, et al.
Published: (2013-12-01)

Medicines in the rehabilitation of patients after myocardial infarction: angiotensin-converting enzyme inhibitors
by: A. S Galyavich
Published: (2010-03-01)

Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
by: Hong-Mi Choi, et al.
Published: (2020-05-01)

Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure
by: Carlsson Marcus, et al.
Published: (2012-07-01)

STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. PASHCHENKO, et al.
Published: (2018-10-01)

Treatment optimization of angiotensin converting enzyme inhibitors and associated factors in Ayder Comprehensive Specialized Hospital: a cross-sectional study
by: Tesfay Mehari Atey, et al.
Published: (2018-03-01)

Use of the Left Ventricular Internal Dimension at End-Diastole and the E-Point Septal Separation Ratio in the Prediction of the Left Ventricular Systolic Function in Patients with Midrange and Reduced Ejection Fractions: A Pilot Study
by: Kahraman Cosansu, et al.
Published: (2019-10-01)

Angiotensin receptor blockers in heart failure after the ELITE II trial
by: Willenheimer Ronnie
Published: (2000-09-01)

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence
by: Eleni-Evangelia Koufou, et al.
Published: (2021-01-01)

Do cardiologists at a university hospital adopt the guidelines for the treatment of heart failure?
by: Antonio Carlos Pereira Barretto, et al.
Published: (2001-07-01)

Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome
by: Ram B. Singh, et al.
Published: (2018-07-01)

Age-related Ventricular Remodeling is an Independent Risk for Heart Failure Symptoms in Subjects With Preserved Systolic Function
by: Chung-Lieh Hung, et al.
Published: (2011-03-01)

Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review
by: Ratih Puspita Febrinasari, et al.
Published: (2019-12-01)

HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY
by: V. V. Mazur, et al.
Published: (2016-01-01)

CHANGING SYTOLIC AND DIASTOLIC LV FUNCTION IN CHRONIC HEART FAILURE UNDER THE INFLUENCE OF METOPROLOL
by: T. S. Jahangirov, et al.
Published: (2001-10-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression
by: George E. Louridas, et al.
Published: (2016-09-01)

Influence of Angiotensin-Converting-Enzyme Gene Polymorphism on Echocardiographic Data of Patients with Ischemic Heart Failure
by: Gustavo Salgado Duque, et al.

Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
by: Mai Nguyen, et al.
Published: (2020-10-01)

Systolic Longitudinal Function of the Left Ventricle Assessed by Speckle Tracking in Heart Failure Patients with Preserved Ejection Fraction
by: Mehrnoush Toufan, et al.
Published: (2016-03-01)

The role of thyrostatic agents in the treatment of chronic heart failure patients with comorbid coronary artery disease and thyrotoxicosis
by: E. V. Pashchenko, et al.
Published: (2021-06-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

The assessment of pressure-volume relationship during exercise stress echocardiography predicts left ventricular remodeling and eccentric hypertrophy in patients with chronic heart failure
by: Iacopo Fabiani, et al.
Published: (2019-04-01)

A per‐protocol initiation of sacubitril/valsartan in an advanced heart failure disease management programme in the Middle East Gulf Region
by: Bassam Atallah, et al.
Published: (2019-08-01)

Quantification of Biventricular Strains in Heart Failure With Preserved Ejection Fraction Patient Using Hyperelastic Warping Method
by: Hua Zou, et al.
Published: (2018-09-01)

THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION
by: R. P. Myasnikov, et al.
Published: (2015-10-01)